Featured Article

GLP-1 Receptor Agonists: A Comprehensive Weigh-In

Kyle Aug 05, 2026

Overview of Weighing In On Glp 1 Receptor Agonists

Weighing in on GLP 1 Receptor Agonists
Weighing in on GLP 1 Receptor Agonists

Glucagon-like peptide-1 ( GLP-1 ) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ago...

What Happens If You Inject Glp1 Into Muscle
What Happens If You Inject Glp1 Into Muscle

Glucagon-like peptide-1 receptor agonists ( GLP-1 RAs) have transformed obesity management, offering substantial weight loss and metabolic benefits. This review examines their expanding role, evaluating efficacy compared to alternative treatments, ...

The expanding role of GLP

From a Glycocentric Approach to Prevention of Multi Organ Damage in Type 2 Diabetes
From a Glycocentric Approach to Prevention of Multi Organ Damage in Type 2 Diabetes

Glucagon-like peptide-1 receptor agonists ( GLP-1 RAs) have transformed obesity management, offering substantial weight loss and metabolic benefits. This review examines their expanding role, evaluating efficacy compared to alternative treatments, emerging indications, ongoing challenges, and future directions. Beyond obesity and type 2 diabetes, the therapeutic potential of GLP-1 RAs extends ...

This review provides a comprehensive and scholarly examination of glucagon-like peptide-1 receptor ( GLP -1R) agonists , tracing their evolution from glycemic control agents in diabetes mellitus (DM) to multifaceted therapeutics with expanding ...

GLP 1 Receptor Agonist Prices List Prices in 2025
GLP 1 Receptor Agonist Prices List Prices in 2025

Useful Notes on Weighing In On Glp 1 Receptor Agonists

The systematic review aimed to assess the effects of GLP-1 receptor agonists ( GLP-1 RA) and dual GLP-1/GIP agonists on weight loss and body composition in individuals with overweight or obesity ...

Since 2014, the pharmacological use of glucagon-like peptide-1 receptor agonists ( GLP-1 RAs), which mimic the gut hormone GLP-1 , has provided an alternative to lifestyle interventions for tackling obesity. GLP-1 RAs suppress appetite and slow gastrointestinal transit time.

GLP 1R Not Just for Blood Sugar Control and Weight Loss DIMA BIOTECH
GLP 1R Not Just for Blood Sugar Control and Weight Loss DIMA BIOTECH

Balancing the benefits and risks of GLP

Glucagon-like peptide-1 receptor agonists ( GLP-1 RAs) are now used widely to manage diabetes, obesity, and an expanding set of metabolic and cardiorenal conditions. As prescribing grows in younger, healthier, and more diverse populations, clinicians increasingly require practical guidance that balances therapeutic benefit with individualized safety considerations. This review synthesizes the ...

OBJECTIVE To provide an updated synthesis on effects of glucagon-like peptide 1 receptor agonists ( GLP-1 RAs) on weight, BMI, and waist circumference incorporating newer randomized controlled trials (RCTs), particularly in individuals with overweight or obesity.

A Closer Look at the Dermatological Profile of GLP 1 Agonists PMC
A Closer Look at the Dermatological Profile of GLP 1 Agonists PMC

Key Details About Weighing In On Glp 1 Receptor Agonists

GLP-1 weight loss clinical guide covering semaglutide, tirzepatide, liraglutide dosing protocols, contraindications, and side effect management for medical providers.

What is GLP 1 and Its Receptor Agonists BOC Sciences
What is GLP 1 and Its Receptor Agonists BOC Sciences
Mechanism of Action of GLP 1
Mechanism of Action of GLP 1
Frontiers GLP 1 receptor agonists for the treatment of obesity Role as a promising approach
Frontiers GLP 1 receptor agonists for the treatment of obesity Role as a promising approach
TrimRX
TrimRX

To complicate matters, pharmaceutical companies are quickly working on new drugs - including triple agonists that target GLP-1 , GIP and glucagon receptors - as well as oral versions of each drug.